News
BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases
BioVaxys Technology Corp. highlights the potential of its novel lipid-in-oil delivery platform, DPXâ„¢, across multiple infectious disease studies and announces its plans for partnering and further development.
BioVaxys' DPXâ„¢ technology is a patented delivery platform that can incorporate a range...
Drug Research
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
Bridge Biotherapeutics, a clinical-stage biotech company announced that it has entered into a joint research agreement with HitGen Inc., a Chinese drug discovery platform company. This collaboration builds on successful initial hit finding and identification work from HitGen's DNA-encoded...
News
Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent
Bora Pharmaceuticals Co., Ltd., a a global leader in pharmaceutical manufacturing announced that it has completed the acquisition from Emergent BioSolutions of its sterile manufacturing facility in Baltimore-Camden, Maryland. The facility adds drug product fill/finish to Bora’s extensive biologics...
News
PCI Pharma Services Successfully Completes International Inspection of New Hampshire Campus
PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), announced in a press release on Aug. 21, 2024 that its Bedford, NH campus successfully completed the multi-agency inspection process of the International Coalition of Medicines Regulatory Authorities...
Drug Research
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses hosted a celebration for the opening of its microbial fermentation manufacturing facility in Billingham. This new facility triples existing...
News
Touchlight, University of Nottingham Partner to Develop Zika DNA Vaccine
Scientists at the University of Nottingham are scaling up the development of a new Zika virus DNA vaccine thanks to a collaboration with specialist company, Touchlight, who will provide new technology to to produce large quantities of the DNA...
News
RedHill announces launch of Talicia in UAE to treat bacterial infection
RedHill Biopharma Ltd. , a specialty biopharmaceutical company announced the launch of Talicia (omeprazole magnesium, amoxicillin and rifabutin) in the United Arab Emirates (UAE) – making it available by prescription to treat adults with Helicobacter pylori (H. pylori) infection....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.